Recombinant DNA Technology Market - Global Outlook and Forecast 2022-2028

March 2022 | 109 pages | ID: R6F01DA43B37EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Recombinant DNA Technology in Global, including the following market information:

Global Recombinant DNA Technology Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Recombinant DNA Technology market was valued at 505 million in 2021 and is projected to reach US$ 653.1 million by 2028, at a CAGR of 3.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Therapeutic Agent Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Recombinant DNA Technology include Monsanto Company, Roche, Biogen, Amgen, Novartis, Eli Lilly and Company, GenScript, Pfizer Inc. and Novo Nordisk, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant DNA Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Recombinant DNA Technology Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Recombinant DNA Technology Market Segment Percentages, by Type, 2021 (%)

• Therapeutic Agent
• Vaccine
• Biotech Crops
• Specialty Chemicals

Global Recombinant DNA Technology Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Recombinant DNA Technology Market Segment Percentages, by Application, 2021 (%)

• Biotechnology and Pharmaceutical Companies
• Academic & Government Research Institutes
• Others

Global Recombinant DNA Technology Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Recombinant DNA Technology Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Recombinant DNA Technology revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Recombinant DNA Technology revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Monsanto Company
• Roche
• Biogen
• Amgen
• Novartis
• Eli Lilly and Company
• GenScript
• Pfizer Inc.
• Novo Nordisk
• Sanofi
• Merck KGaA
• Profacgen
• Biocon
• GlaxoSmithKline
• Cibus
• Horizon Discovery Group
• New England Biolabs

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Recombinant DNA Technology Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Recombinant DNA Technology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RECOMBINANT DNA TECHNOLOGY OVERALL MARKET SIZE

2.1 Global Recombinant DNA Technology Market Size: 2021 VS 2028
2.2 Global Recombinant DNA Technology Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Recombinant DNA Technology Players in Global Market
3.2 Top Global Recombinant DNA Technology Companies Ranked by Revenue
3.3 Global Recombinant DNA Technology Revenue by Companies
3.4 Top 3 and Top 5 Recombinant DNA Technology Companies in Global Market, by Revenue in 2021
3.5 Global Companies Recombinant DNA Technology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Recombinant DNA Technology Players in Global Market
  3.6.1 List of Global Tier 1 Recombinant DNA Technology Companies
  3.6.2 List of Global Tier 2 and Tier 3 Recombinant DNA Technology Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Recombinant DNA Technology Market Size Markets, 2021 & 2028
  4.1.2 Therapeutic Agent
  4.1.3 Vaccine
  4.1.4 Biotech Crops
  4.1.5 Specialty Chemicals
4.2 By Type - Global Recombinant DNA Technology Revenue & Forecasts
  4.2.1 By Type - Global Recombinant DNA Technology Revenue, 2017-2022
  4.2.2 By Type - Global Recombinant DNA Technology Revenue, 2023-2028
  4.2.3 By Type - Global Recombinant DNA Technology Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Recombinant DNA Technology Market Size, 2021 & 2028
  5.1.2 Biotechnology and Pharmaceutical Companies
  5.1.3 Academic & Government Research Institutes
  5.1.4 Others
5.2 By Application - Global Recombinant DNA Technology Revenue & Forecasts
  5.2.1 By Application - Global Recombinant DNA Technology Revenue, 2017-2022
  5.2.2 By Application - Global Recombinant DNA Technology Revenue, 2023-2028
  5.2.3 By Application - Global Recombinant DNA Technology Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Recombinant DNA Technology Market Size, 2021 & 2028
6.2 By Region - Global Recombinant DNA Technology Revenue & Forecasts
  6.2.1 By Region - Global Recombinant DNA Technology Revenue, 2017-2022
  6.2.2 By Region - Global Recombinant DNA Technology Revenue, 2023-2028
  6.2.3 By Region - Global Recombinant DNA Technology Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Recombinant DNA Technology Revenue, 2017-2028
  6.3.2 US Recombinant DNA Technology Market Size, 2017-2028
  6.3.3 Canada Recombinant DNA Technology Market Size, 2017-2028
  6.3.4 Mexico Recombinant DNA Technology Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Recombinant DNA Technology Revenue, 2017-2028
  6.4.2 Germany Recombinant DNA Technology Market Size, 2017-2028
  6.4.3 France Recombinant DNA Technology Market Size, 2017-2028
  6.4.4 U.K. Recombinant DNA Technology Market Size, 2017-2028
  6.4.5 Italy Recombinant DNA Technology Market Size, 2017-2028
  6.4.6 Russia Recombinant DNA Technology Market Size, 2017-2028
  6.4.7 Nordic Countries Recombinant DNA Technology Market Size, 2017-2028
  6.4.8 Benelux Recombinant DNA Technology Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Recombinant DNA Technology Revenue, 2017-2028
  6.5.2 China Recombinant DNA Technology Market Size, 2017-2028
  6.5.3 Japan Recombinant DNA Technology Market Size, 2017-2028
  6.5.4 South Korea Recombinant DNA Technology Market Size, 2017-2028
  6.5.5 Southeast Asia Recombinant DNA Technology Market Size, 2017-2028
  6.5.6 India Recombinant DNA Technology Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Recombinant DNA Technology Revenue, 2017-2028
  6.6.2 Brazil Recombinant DNA Technology Market Size, 2017-2028
  6.6.3 Argentina Recombinant DNA Technology Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Recombinant DNA Technology Revenue, 2017-2028
  6.7.2 Turkey Recombinant DNA Technology Market Size, 2017-2028
  6.7.3 Israel Recombinant DNA Technology Market Size, 2017-2028
  6.7.4 Saudi Arabia Recombinant DNA Technology Market Size, 2017-2028
  6.7.5 UAE Recombinant DNA Technology Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Monsanto Company
  7.1.1 Monsanto Company Corporate Summary
  7.1.2 Monsanto Company Business Overview
  7.1.3 Monsanto Company Recombinant DNA Technology Major Product Offerings
  7.1.4 Monsanto Company Recombinant DNA Technology Revenue in Global Market (2017-2022)
  7.1.5 Monsanto Company Key News
7.2 Roche
  7.2.1 Roche Corporate Summary
  7.2.2 Roche Business Overview
  7.2.3 Roche Recombinant DNA Technology Major Product Offerings
  7.2.4 Roche Recombinant DNA Technology Revenue in Global Market (2017-2022)
  7.2.5 Roche Key News
7.3 Biogen
  7.3.1 Biogen Corporate Summary
  7.3.2 Biogen Business Overview
  7.3.3 Biogen Recombinant DNA Technology Major Product Offerings
  7.3.4 Biogen Recombinant DNA Technology Revenue in Global Market (2017-2022)
  7.3.5 Biogen Key News
7.4 Amgen
  7.4.1 Amgen Corporate Summary
  7.4.2 Amgen Business Overview
  7.4.3 Amgen Recombinant DNA Technology Major Product Offerings
  7.4.4 Amgen Recombinant DNA Technology Revenue in Global Market (2017-2022)
  7.4.5 Amgen Key News
7.5 Novartis
  7.5.1 Novartis Corporate Summary
  7.5.2 Novartis Business Overview
  7.5.3 Novartis Recombinant DNA Technology Major Product Offerings
  7.5.4 Novartis Recombinant DNA Technology Revenue in Global Market (2017-2022)
  7.5.5 Novartis Key News
7.6 Eli Lilly and Company
  7.6.1 Eli Lilly and Company Corporate Summary
  7.6.2 Eli Lilly and Company Business Overview
  7.6.3 Eli Lilly and Company Recombinant DNA Technology Major Product Offerings
  7.6.4 Eli Lilly and Company Recombinant DNA Technology Revenue in Global Market (2017-2022)
  7.6.5 Eli Lilly and Company Key News
7.7 GenScript
  7.7.1 GenScript Corporate Summary
  7.7.2 GenScript Business Overview
  7.7.3 GenScript Recombinant DNA Technology Major Product Offerings
  7.7.4 GenScript Recombinant DNA Technology Revenue in Global Market (2017-2022)
  7.7.5 GenScript Key News
7.8 Pfizer Inc.
  7.8.1 Pfizer Inc. Corporate Summary
  7.8.2 Pfizer Inc. Business Overview
  7.8.3 Pfizer Inc. Recombinant DNA Technology Major Product Offerings
  7.8.4 Pfizer Inc. Recombinant DNA Technology Revenue in Global Market (2017-2022)
  7.8.5 Pfizer Inc. Key News
7.9 Novo Nordisk
  7.9.1 Novo Nordisk Corporate Summary
  7.9.2 Novo Nordisk Business Overview
  7.9.3 Novo Nordisk Recombinant DNA Technology Major Product Offerings
  7.9.4 Novo Nordisk Recombinant DNA Technology Revenue in Global Market (2017-2022)
  7.9.5 Novo Nordisk Key News
7.10 Sanofi
  7.10.1 Sanofi Corporate Summary
  7.10.2 Sanofi Business Overview
  7.10.3 Sanofi Recombinant DNA Technology Major Product Offerings
  7.10.4 Sanofi Recombinant DNA Technology Revenue in Global Market (2017-2022)
  7.10.5 Sanofi Key News
7.11 Merck KGaA
  7.11.1 Merck KGaA Corporate Summary
  7.11.2 Merck KGaA Business Overview
  7.11.3 Merck KGaA Recombinant DNA Technology Major Product Offerings
  7.11.4 Merck KGaA Recombinant DNA Technology Revenue in Global Market (2017-2022)
  7.11.5 Merck KGaA Key News
7.12 Profacgen
  7.12.1 Profacgen Corporate Summary
  7.12.2 Profacgen Business Overview
  7.12.3 Profacgen Recombinant DNA Technology Major Product Offerings
  7.12.4 Profacgen Recombinant DNA Technology Revenue in Global Market (2017-2022)
  7.12.5 Profacgen Key News
7.13 Biocon
  7.13.1 Biocon Corporate Summary
  7.13.2 Biocon Business Overview
  7.13.3 Biocon Recombinant DNA Technology Major Product Offerings
  7.13.4 Biocon Recombinant DNA Technology Revenue in Global Market (2017-2022)
  7.13.5 Biocon Key News
7.14 GlaxoSmithKline
  7.14.1 GlaxoSmithKline Corporate Summary
  7.14.2 GlaxoSmithKline Business Overview
  7.14.3 GlaxoSmithKline Recombinant DNA Technology Major Product Offerings
  7.14.4 GlaxoSmithKline Recombinant DNA Technology Revenue in Global Market (2017-2022)
  7.14.5 GlaxoSmithKline Key News
7.15 Cibus
  7.15.1 Cibus Corporate Summary
  7.15.2 Cibus Business Overview
  7.15.3 Cibus Recombinant DNA Technology Major Product Offerings
  7.15.4 Cibus Recombinant DNA Technology Revenue in Global Market (2017-2022)
  7.15.5 Cibus Key News
7.16 Horizon Discovery Group
  7.16.1 Horizon Discovery Group Corporate Summary
  7.16.2 Horizon Discovery Group Business Overview
  7.16.3 Horizon Discovery Group Recombinant DNA Technology Major Product Offerings
  7.16.4 Horizon Discovery Group Recombinant DNA Technology Revenue in Global Market (2017-2022)
  7.16.5 Horizon Discovery Group Key News
7.17 New England Biolabs
  7.17.1 New England Biolabs Corporate Summary
  7.17.2 New England Biolabs Business Overview
  7.17.3 New England Biolabs Recombinant DNA Technology Major Product Offerings
  7.17.4 New England Biolabs Recombinant DNA Technology Revenue in Global Market (2017-2022)
  7.17.5 New England Biolabs Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Recombinant DNA Technology Market Opportunities & Trends in Global Market
Table 2. Recombinant DNA Technology Market Drivers in Global Market
Table 3. Recombinant DNA Technology Market Restraints in Global Market
Table 4. Key Players of Recombinant DNA Technology in Global Market
Table 5. Top Recombinant DNA Technology Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Recombinant DNA Technology Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Recombinant DNA Technology Revenue Share by Companies, 2017-2022
Table 8. Global Companies Recombinant DNA Technology Product Type
Table 9. List of Global Tier 1 Recombinant DNA Technology Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant DNA Technology Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Recombinant DNA Technology Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Recombinant DNA Technology Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Recombinant DNA Technology Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Recombinant DNA Technology Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Recombinant DNA Technology Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Recombinant DNA Technology Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Recombinant DNA Technology Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Recombinant DNA Technology Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Recombinant DNA Technology Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Recombinant DNA Technology Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Recombinant DNA Technology Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Recombinant DNA Technology Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Recombinant DNA Technology Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Recombinant DNA Technology Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Recombinant DNA Technology Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Recombinant DNA Technology Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Recombinant DNA Technology Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Recombinant DNA Technology Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Recombinant DNA Technology Revenue, (US$, Mn), 2023-2028
Table 30. Monsanto Company Corporate Summary
Table 31. Monsanto Company Recombinant DNA Technology Product Offerings
Table 32. Monsanto Company Recombinant DNA Technology Revenue (US$, Mn), (2017-2022)
Table 33. Roche Corporate Summary
Table 34. Roche Recombinant DNA Technology Product Offerings
Table 35. Roche Recombinant DNA Technology Revenue (US$, Mn), (2017-2022)
Table 36. Biogen Corporate Summary
Table 37. Biogen Recombinant DNA Technology Product Offerings
Table 38. Biogen Recombinant DNA Technology Revenue (US$, Mn), (2017-2022)
Table 39. Amgen Corporate Summary
Table 40. Amgen Recombinant DNA Technology Product Offerings
Table 41. Amgen Recombinant DNA Technology Revenue (US$, Mn), (2017-2022)
Table 42. Novartis Corporate Summary
Table 43. Novartis Recombinant DNA Technology Product Offerings
Table 44. Novartis Recombinant DNA Technology Revenue (US$, Mn), (2017-2022)
Table 45. Eli Lilly and Company Corporate Summary
Table 46. Eli Lilly and Company Recombinant DNA Technology Product Offerings
Table 47. Eli Lilly and Company Recombinant DNA Technology Revenue (US$, Mn), (2017-2022)
Table 48. GenScript Corporate Summary
Table 49. GenScript Recombinant DNA Technology Product Offerings
Table 50. GenScript Recombinant DNA Technology Revenue (US$, Mn), (2017-2022)
Table 51. Pfizer Inc. Corporate Summary
Table 52. Pfizer Inc. Recombinant DNA Technology Product Offerings
Table 53. Pfizer Inc. Recombinant DNA Technology Revenue (US$, Mn), (2017-2022)
Table 54. Novo Nordisk Corporate Summary
Table 55. Novo Nordisk Recombinant DNA Technology Product Offerings
Table 56. Novo Nordisk Recombinant DNA Technology Revenue (US$, Mn), (2017-2022)
Table 57. Sanofi Corporate Summary
Table 58. Sanofi Recombinant DNA Technology Product Offerings
Table 59. Sanofi Recombinant DNA Technology Revenue (US$, Mn), (2017-2022)
Table 60. Merck KGaA Corporate Summary
Table 61. Merck KGaA Recombinant DNA Technology Product Offerings
Table 62. Merck KGaA Recombinant DNA Technology Revenue (US$, Mn), (2017-2022)
Table 63. Profacgen Corporate Summary
Table 64. Profacgen Recombinant DNA Technology Product Offerings
Table 65. Profacgen Recombinant DNA Technology Revenue (US$, Mn), (2017-2022)
Table 66. Biocon Corporate Summary
Table 67. Biocon Recombinant DNA Technology Product Offerings
Table 68. Biocon Recombinant DNA Technology Revenue (US$, Mn), (2017-2022)
Table 69. GlaxoSmithKline Corporate Summary
Table 70. GlaxoSmithKline Recombinant DNA Technology Product Offerings
Table 71. GlaxoSmithKline Recombinant DNA Technology Revenue (US$, Mn), (2017-2022)
Table 72. Cibus Corporate Summary
Table 73. Cibus Recombinant DNA Technology Product Offerings
Table 74. Cibus Recombinant DNA Technology Revenue (US$, Mn), (2017-2022)
Table 75. Horizon Discovery Group Corporate Summary
Table 76. Horizon Discovery Group Recombinant DNA Technology Product Offerings
Table 77. Horizon Discovery Group Recombinant DNA Technology Revenue (US$, Mn), (2017-2022)
Table 78. New England Biolabs Corporate Summary
Table 79. New England Biolabs Recombinant DNA Technology Product Offerings
Table 80. New England Biolabs Recombinant DNA Technology Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Recombinant DNA Technology Segment by Type in 2021
Figure 2. Recombinant DNA Technology Segment by Application in 2021
Figure 3. Global Recombinant DNA Technology Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Recombinant DNA Technology Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Recombinant DNA Technology Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Recombinant DNA Technology Revenue in 2021
Figure 8. By Type - Global Recombinant DNA Technology Revenue Market Share, 2017-2028
Figure 9. By Application - Global Recombinant DNA Technology Revenue Market Share, 2017-2028
Figure 10. By Region - Global Recombinant DNA Technology Revenue Market Share, 2017-2028
Figure 11. By Country - North America Recombinant DNA Technology Revenue Market Share, 2017-2028
Figure 12. US Recombinant DNA Technology Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Recombinant DNA Technology Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Recombinant DNA Technology Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Recombinant DNA Technology Revenue Market Share, 2017-2028
Figure 16. Germany Recombinant DNA Technology Revenue, (US$, Mn), 2017-2028
Figure 17. France Recombinant DNA Technology Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Recombinant DNA Technology Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Recombinant DNA Technology Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Recombinant DNA Technology Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Recombinant DNA Technology Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Recombinant DNA Technology Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Recombinant DNA Technology Revenue Market Share, 2017-2028
Figure 24. China Recombinant DNA Technology Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Recombinant DNA Technology Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Recombinant DNA Technology Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Recombinant DNA Technology Revenue, (US$, Mn), 2017-2028
Figure 28. India Recombinant DNA Technology Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Recombinant DNA Technology Revenue Market Share, 2017-2028
Figure 30. Brazil Recombinant DNA Technology Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Recombinant DNA Technology Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Recombinant DNA Technology Revenue Market Share, 2017-2028
Figure 33. Turkey Recombinant DNA Technology Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Recombinant DNA Technology Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Recombinant DNA Technology Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Recombinant DNA Technology Revenue, (US$, Mn), 2017-2028
Figure 37. Monsanto Company Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Roche Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Biogen Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Amgen Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Eli Lilly and Company Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. GenScript Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Pfizer Inc. Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Novo Nordisk Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Sanofi Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Merck KGaA Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Profacgen Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Biocon Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. GlaxoSmithKline Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Cibus Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Horizon Discovery Group Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. New England Biolabs Recombinant DNA Technology Revenue Year Over Year Growth (US$, Mn) & (2017-2022)